For some people who need HIV medication, daily pills aren’t always the ideal solution. If you have barriers to taking daily pills, long-acting injectable antiretroviral therapy (LAI) is a highly effective alternative. This advanced approach gives you the treatment you need through shots every month or every two months. These medications work for both prevention and treatment of HIV.  

Since 2022, Mount Sinai’s Institute for Advanced Medicine (IAM) has pioneered use of these injectable antiretroviral medications. We offer the following drugs:

• For prevention of HIV: Injectable PrEP also known as long-acting cabotegravir (Apretude)
• For treatment of HIV: A combination of long-acting cabotegravir and rilpivirine (Cabenuva) and lenacapavir (Sunlenca) ®

You can receive your injections at the IAM office where you receive your PrEP and primary care.

Services We Offer

We provide full support for patients receiving injectable antiretroviral therapy. This includes:

• Assessing your needs and eligibility
• Providing in-depth education on your treatment options and their benefits
• Helping you with insurance and pre-authorization
• Providing injections
• Offering ongoing monitoring and follow-up care

Referral Process

We accept referrals from:

• Health care providers within the Mount Sinai Health System
• Community health care providers
• Self-referrals

We strive to get you the care you need as efficiently as possible. We will evaluate you to make sure these medications are the right choice for you.

Insurance Coverage

We accept most major insurance plans. This includes Medicare and Medicaid. We have dedicated patient advocates to help you get the best insurance coverage available. Our team works closely with insurance providers to give you access to these treatments.